CVI Holdings’s Cellectar Biosciences, Inc. Series A Warrants CLRBZ Stock Holding History

CVI Holdings’s Portfolio CLRBZ Stock Details CLRBZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-207,500	Closed	-$39K	–	61
2018 Q2	$39K	Hold	207,500	–	–	0.05%	40
2018 Q1	$87K	Buy	+207,500	New	+$102K	0.12%	32

Other funds holding CLRBZ

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CVI Holdings's CLRBZ Position: Q3 2018 in Review

CVI Holdings sold out of Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) in Q3 2018, closing a stake of 207,500 shares — an estimated $39K sold.

CVI Holdings first reported a position in CLRBZ in Q1 2018 and held it in 2 quarters. The position peaked at $87K in Q1 2018. 1 fund tracked by Wall St. Rank holds CLRBZ as of Q3 2018.

CVI Holdings reported no remaining Cellectar Biosciences, Inc. Series A Warrants position as of Q3 2018 after selling out during the quarter.
CVI Holdings sold 207,500 Cellectar Biosciences, Inc. Series A Warrants shares in Q3 2018, an estimated $39K.
CVI Holdings first reported a position in Cellectar Biosciences, Inc. Series A Warrants in Q1 2018 and held it in 2 quarters.
CVI Holdings's Cellectar Biosciences, Inc. Series A Warrants position peaked at $87K in Q1 2018.
1 fund tracked by Wall St. Rank held Cellectar Biosciences, Inc. Series A Warrants as of Q3 2018.

Based on CVI Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.